Correlation Between DiaMedica Therapeutics and Skye Bioscience,

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Skye Bioscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Skye Bioscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and Skye Bioscience, Common, you can compare the effects of market volatilities on DiaMedica Therapeutics and Skye Bioscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Skye Bioscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Skye Bioscience,.

Diversification Opportunities for DiaMedica Therapeutics and Skye Bioscience,

-0.48

Correlation Coefficient

DiaMedica Therapeutics  Skye Bioscience,

Very good diversification

The 3 months correlation between DiaMedica and Skye is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Skye Bioscience, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Skye Bioscience, Common and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Skye Bioscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Skye Bioscience, Common has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Skye Bioscience, go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Skye Bioscience,

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.79 times more return on investment than Skye Bioscience,. However, DiaMedica Therapeutics is 1.79 times more volatile than Skye Bioscience, Common. It trades about 0.11 of its potential returns per unit of risk. Skye Bioscience, Common is currently generating about -0.41 per unit of risk. If you would invest  462.00  in DiaMedica Therapeutics on September 25, 2024 and sell it today you would earn a total of  64.00  from holding DiaMedica Therapeutics or generate 13.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  Skye Bioscience, Common

DiaMedica Therapeutics

Risk-Adjusted Performance

7 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Skye Bioscience, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Skye Bioscience, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with DiaMedica Therapeutics and Skye Bioscience,

The main advantage of trading using opposite DiaMedica Therapeutics and Skye Bioscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Skye Bioscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Skye Bioscience, will offset losses from the drop in Skye Bioscience,'s long position.

The idea behind DiaMedica Therapeutics and Skye Bioscience, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.